Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases - PubMed (original) (raw)
. 2006 Mar-Apr;53(68):275-80.
Affiliations
- PMID: 16608039
Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases
Jian Zhou et al. Hepatogastroenterology. 2006 Mar-Apr.
Abstract
Background/aims: The prognosis ofhepatocellular carcinoma with macroscopic portal vein tumor thrombosis is extremely poor. The risk factors may differ at different postoperative intervals. This study was undertaken to clarify the surgical outcome and time dependency of factors influencing survival in these patients.
Methodology: We analyzed clinicopathological variables of 381 hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis who underwent hepatic resection. Survival rates were calculated using Kaplan-Meier method. The stratified Cox models were used to identify factors independently influencing short- and long-term survival, respectively.
Results: The cumulative 1-, 2-, 3-, 5-, and 10-year survival rates in 381 patients were 47%, 23%, 16%, 12%, 6%, respectively. The 1-, 3-, and 5-year survival rates calculated from time of re-resection were 36%, 14% and 0% in patients undergoing re-resection for intrahepatic recurrence within 2 years after first operation, and 85%, 53% and 32% in those more than 2 years after first operation (P<0.05). Multivariate analysis showed that portal vein infusion chemotherapy, serum alpha-fetoprotein > 20 mg/L and positive surgical margin were significant prognostic factors within 2 years after operation. In contrast, alanine aminotransferase > 80 U/L was the only significant factor beyond 2 years after operation.
Conclusions: The survival of hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis was poor, but the prognosis of patients who had tumor recurrence more than 2 years after operation was much better than those with tumor recurrence within 2 years. Evaluation of time-dependency of risk factors may have important clinical implication in determining the therapeutic strategy.
Similar articles
- [Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery].
Zhou J, Fan J, Tang ZY, Wu ZQ, Zhou XD, Ma ZC, Tan CJ, Shi YH, Yu Y, Qiu SJ. Zhou J, et al. Zhonghua Yi Xue Za Zhi. 2006 Nov 14;86(42):3005-8. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17288818 Chinese. - Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein.
Ikai I, Hatano E, Hasegawa S, Fujii H, Taura K, Uyama N, Shimahara Y. Ikai I, et al. J Am Coll Surg. 2006 Mar;202(3):431-8. doi: 10.1016/j.jamcollsurg.2005.11.012. Epub 2006 Jan 20. J Am Coll Surg. 2006. PMID: 16500247 - [Prognostic factors influencing postoperative survival in patients with </= 3 cm small hepatocellular carcinoma].
Wu FS, Zhao WH, Liang TB, Ren GP, Ma ZM, Teng LS. Wu FS, et al. Zhonghua Wai Ke Za Zhi. 2005 May 1;43(9):579-83. Zhonghua Wai Ke Za Zhi. 2005. PMID: 15938929 Chinese. - Management of hepatocellular carcinoma: long-term outcome in 2639 cases.
Zhou XD, Tang ZY. Zhou XD, et al. Gan To Kagaku Ryoho. 1997 May;24 Suppl 1:9-16. Gan To Kagaku Ryoho. 1997. PMID: 9210883 Review. - Advances in hepatic resection and results for hepatocellular carcinoma.
Nonami T, Harada A, Kurokawa T, Nakao A, Takagi H. Nonami T, et al. Semin Surg Oncol. 1996 May-Jun;12(3):183-8. doi: 10.1002/(SICI)1098-2388(199605/06)12:3<183::AID-SSU7>3.0.CO;2-3. Semin Surg Oncol. 1996. PMID: 8727608 Review.
Cited by
- Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.
Sun L, Guan YS, Pan WM, Chen GB, Luo ZM, Wei JH, Wu H. Sun L, et al. World J Gastroenterol. 2008 Feb 28;14(8):1212-7. doi: 10.3748/wjg.14.1212. World J Gastroenterol. 2008. PMID: 18300346 Free PMC article. - Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence.
Koh YX, Tan HL, Lye WK, Kam JH, Chiow AKH, Tan SS, Choo SP, Chung AYF, Goh BKP. Koh YX, et al. World J Hepatol. 2018 Jun 27;10(6):433-447. doi: 10.4254/wjh.v10.i6.433. World J Hepatol. 2018. PMID: 29988922 Free PMC article. - FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma.
Wang F, Qiao Y, Yu J, Ren X, Wang J, Ding Y, Zhang X, Ma W, Ding Y, Liang L. Wang F, et al. PLoS One. 2013 Jun 27;8(6):e65495. doi: 10.1371/journal.pone.0065495. Print 2013. PLoS One. 2013. PMID: 23826080 Free PMC article. - Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion.
Zhong JH, Rodríguez AC, Ke Y, Wang YY, Wang L, Li LQ. Zhong JH, et al. Medicine (Baltimore). 2015 Jan;94(3):e396. doi: 10.1097/MD.0000000000000396. Medicine (Baltimore). 2015. PMID: 25621684 Free PMC article. Review. - New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch.
Fukumoto T, Kido M, Takebe A, Tanaka M, Kinoshita H, Kuramitsu K, Komatsu S, Tsugawa D, Goto T, Asari S, Toyama H, Ajiki T, Ku Y. Fukumoto T, et al. Surg Today. 2017 Sep;47(9):1094-1103. doi: 10.1007/s00595-017-1507-9. Epub 2017 Mar 21. Surg Today. 2017. PMID: 28324163
MeSH terms
LinkOut - more resources
Medical